Healthcare - Biotechnology - NASDAQ - US
$ 1.72
-2.82 %
$ 29.1 M
Market Cap
-1.52
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
--3.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Acurx Pharmaceuticals, Inc.
ACXP has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ACXP
EBIT FORECAST
EBIT Forecast Chart ACXP
NET INCOME FORECAST
Net Income Chart ACXP